Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Volitionrx Ltd

Healthcare US VNRX

0.2USD
0.0002(0.10%)

Last update at 2026-03-10T20:06:00Z

Day Range

0.190.20
LowHigh

52 Week Range

0.552.70
LowHigh

Fundamentals

  • Previous Close 0.20
  • Market Cap54.84M
  • Volume653353
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-34.15287M
  • Revenue TTM0.65M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 0.31M
  • Diluted EPS TTM-0.54

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -30.59847M -26.98978M -20.39929M -16.09905M -18.00862M
Minority interest 0.33M 0.18M -0.04718M -0.04718M -0.04718M
Net income -30.26879M -26.97047M -20.48191M -16.02867M -18.00862M
Selling general administrative 16.11M 8.62M 5.47M 4.52M 5.78M
Selling and marketing expenses 1.05M 4.13M 1.07M 0.97M 1.17M
Gross profit 0.31M 0.09M 0.01M 0.02M 0.00000M
Reconciled depreciation 1.19M 1.15M 1.04M 0.90M 0.64M
Ebit -31.78007M -28.33308M -21.24781M -16.04292M -17.89770M
Ebitda -29.23543M -25.66265M -19.52143M -15.07007M -17.26132M
Depreciation and amortization 2.54M 2.67M 1.73M 0.97M 0.64M
Non operating income net other - - 0.98M 0.11M -
Operating income -31.78007M -28.33308M -21.24781M -16.04292M -17.89770M
Other operating expenses 30.86M 26.90M 20.63M 15.90M 17.90M
Interest expense 0.17M 0.16M 0.13M 0.13M 0.11M
Tax provision - - - - -
Interest income 0.13M 0.00273M 0.05M 0.11M 0.11M
Net interest income -0.04782M -0.15307M -0.08030M -0.01421M -0.11092M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.32968M -0.01931M 0.08M -0.07039M 0.11M
Total revenue 0.31M 0.09M 0.01M 0.02M 0.00000M
Total operating expenses 30.86M 26.90M 20.63M 15.90M 17.90M
Cost of revenue - - - - 0.00000M
Total other income expense net 1.18M 1.34M 0.85M -0.05613M -0.11092M
Discontinued operations - - - - -
Net income from continuing ops -31.78007M -26.98978M -20.39929M -16.09905M -18.00862M
Net income applicable to common shares -30.59847M -26.81467M -20.35212M -16.09905M -18.00862M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 18.30M 27.49M 26.15M 21.29M 17.49M
Intangible assets 0.11M 0.22M 0.32M 0.37M 0.47M
Earning assets - - - - -
Other current assets 0.45M 0.79M 0.58M 0.32M 0.23M
Total liab 21.42M 9.77M 9.86M 7.09M 5.35M
Total stockholder equity -2.57499M 17.94M 16.34M 14.20M 12.14M
Deferred long term liab - - - - -
Other current liab 2.99M 3.96M 3.55M 2.19M 0.92M
Common stock 0.06M 0.05M 0.05M 0.04M 0.04M
Capital stock 0.06M 0.05M 0.05M 0.04M 0.04M
Retained earnings -167.25743M -136.98864M -110.17397M -89.82186M -73.72280M
Other liab 0.42M 0.25M 0.26M 0.30M 0.31M
Good will - - - - -
Other assets - - - - -
Cash 10.87M 20.58M 19.44M 16.97M 13.43M
Cash and equivalents - - - - -
Total current liabilities 17.39M 6.52M 6.24M 3.86M 2.33M
Current deferred revenue 10.00M - 0.07M 0.04M 0.04M
Net debt -5.89371M -16.56418M -15.00318M -13.02855M -10.16124M
Short term debt 1.36M 1.02M 1.08M 1.00M 0.56M
Short long term debt 1.07M 0.80M 0.84M 0.65M 0.42M
Short long term debt total 4.97M 4.02M 4.44M 3.94M 3.27M
Other stockholder equity 164.40M 154.73M 126.53M 103.85M 85.60M
Property plant equipment 5.39M 5.29M 5.50M 3.36M 3.12M
Total current assets 12.17M 21.98M 20.33M 17.56M 13.90M
Long term investments - - - - -
Net tangible assets -3.23747M 17.73M 16.02M 13.83M 11.67M
Short term investments - - - - -
Net receivables 0.07M 0.01M 0.00712M - -
Long term debt 2.78M 2.27M 2.61M 2.20M 1.98M
Inventory 0.78M 0.60M 0.30M - -
Accounts payable 3.04M 1.54M 1.54M 0.63M 0.81M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.23M 0.15M -0.05998M 0.13M 0.22M
Additional paid in capital - - - - -
Common stock total equity 0.06M - 0.05M 0.04M 0.04M
Preferred stock total equity - - - - -
Retained earnings total equity -167.25743M - -110.17397M -89.82186M -73.72280M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.62M - - -0.00001M 0.00001M
Deferred long term asset charges - - - - -
Non current assets total 6.12M 5.51M 5.82M 3.74M 3.59M
Capital lease obligations 1.13M 0.95M 0.99M 1.09M 0.87M
Long term debt total 2.78M - - 3.10M 3.02M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.57018M -0.97356M -1.64775M -0.51127M -0.30180M
Change to liabilities 10.54M 0.53M 2.05M 1.11M 0.07M
Total cashflows from investing activities -1.57018M -0.97356M -1.64775M -0.51127M -0.30180M
Net borrowings 0.25M -0.22151M -0.29634M 0.03M 0.59M
Total cash from financing activities 6.94M 22.86M 20.62M 16.93M 17.97M
Change to operating activities 0.55M -0.67833M -0.58411M -0.31209M -0.05409M
Net income -30.59847M -26.98978M -20.39929M -16.09905M -18.00862M
Change in cash -9.71426M 1.14M 2.48M 3.54M 3.31M
Begin period cash flow 20.58M 19.44M 16.97M 13.43M 10.12M
End period cash flow 10.87M 20.58M 19.44M 16.97M 13.43M
Total cash from operating activities -15.27774M -20.85392M -16.46424M -12.73945M -14.73303M
Issuance of capital stock 6.74M 23.22M 21.20M 16.59M 17.25M
Depreciation 1.19M 1.15M 1.04M 0.90M 0.64M
Other cashflows from investing activities - - 0.29M - -
Dividends paid - - -0.34647M - -
Change to inventory - -0.48186M -0.25653M - -
Change to account receivables -0.07261M -0.01251M -0.00712M -0.00712M -0.00712M
Sale purchase of stock 6.74M 0.00000M -0.05443M 16.59M 17.25M
Other cashflows from financing activities 1.52M 0.45M 0.47M 0.83M 1.30M
Change to netincome 2.78M 4.97M 1.38M 1.46M 2.57M
Capital expenditures 1.57M 0.97M 1.94M 0.51M 0.30M
Change receivables 0.07M - -0.00712M - -
Cash flows other operating -1.01839M - -0.25892M -0.02208M 0.00288M
Exchange rate changes - - -0.03028M -0.13986M 0.38M
Cash and cash equivalents changes -9.90989M - 2.48M 3.54M 3.31M
Change in working capital 11.02M -0.15611M 1.46M 0.79M 0.05M
Stock based compensation 3.11M 5.12M 1.73M 1.46M 2.57M
Other non cash items - 0.03M -0.29331M 0.21M 0.02M
Free cash flow -16.84792M -21.82748M -18.40530M -13.25072M -15.03483M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VNRX
Volitionrx Ltd		 0.0002 0.10% 0.20 - - 79.78 38.44 69.79 -1.3923
TMO
Thermo Fisher Scientific Inc		 -9.89 1.94% 500.08 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 -3.58 1.80% 195.22 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 -1.21 1.04% 115.43 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -11.6 1.90% 598.85 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.

Volitionrx Ltd

13215 Bee Cave Parkway, Austin, TX, United States, 78738

Key Executives

Name Title Year Born
Dr. Martin Charles Faulkes Ph.D. Exec. Chairman 1944
Mr. Cameron Reynolds MBA Founder, Group CEO, Pres & Director 1971
Mr. Terig Hughes Group CFO & Treasurer 1971
Dr. Jacob Vincent Micallef Chief Scientific Officer 1956
Dr. Salvatore Thomas Butera Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC 1951
Dr. Gaetan Michel Ph.D. Chief Operating Officer 1973
Dr. Mark Eccleston M.B.A., Ph.D. Chief Technology Officer 1971
Mr. Scott Powell Ph.D. Exec. VP of Investor Relations & CFO of Volition America Inc 1974
Mr. Nicholas Plummer Group Gen. Counsel 1971
Ms. Louise Batchelor Day Chief Marketing & Communications Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.